Delivery Order SPE2DB24D2100-SPE2DB25FBBMD
Award Date
12/30/24
Potential Completion Date
12/31/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,597.37 firm fixed-price delivery order is for the supply of Celecoxib 200 mg capsules, a medication used to treat pain and inflammation. The contract has an ultimate completion date of August 23, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,090.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 14, 2024. The contract is for the delivery of 4,566,722,945 units of the medication Celecoxib 200 mg capsules, with a completion date of December 16, 2024.
The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,431.05 contract is for the delivery of 100 units of Celecoxib 200 mg capsules, with a performance period ending on August 1, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,619.93 firm fixed price delivery order is for the supply of 100 milligram Celebrex capsules. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order, valued at $6,226.47, is for the provision of 4,557,045,363 units of Celecoxib 200 mg capsules. The contract has a period of performance through April 29, 2022 and is a firm fixed-price delivery order. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The firm-fixed-price delivery order, valued at $4,984.32, is for the supply of 4,558,367,766 capsules of Celecoxib 100 mg, a medication used to treat certain types of arthritis and pain. The contract has a completion date of September 8, 2022.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $361,252.95 delivery order is for the supply of 4,531,831,739 units of the pharmaceutical drug Celecoxib 200mg. The award is for delivery by October 7, 2015 and does not have a set-aside designation, indicating open competition.
Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $202,762.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,531,932 units of Celecoxib 200mg capsules, a pharmaceutical product used for pain management.
The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued up to $999,999,999.00 and running...
This contract award is for the delivery of 4,564,658,933 units of celecoxib 200mg capsules to the U.S. Defense Logistics Agency (DLA). The contract, valued at $5,562.03, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the federal government. The delivery order is a firm fixed-price contract with a completion date of May 21, 2024.
Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of celecoxib 200mg capsules. The firm-fixed-price contract has a ceiling value of $6,408.14 and a period of performance through May 15, 2024.
Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...